7 completed, 1 not yet recruiting, 1 unknown. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 7, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Pyrazinamide: new trials by email Literature Review of Pyrazinamide trials Research Report on Pyrazinamide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi Silymarin 420 mg, N Acetyl Cysteine, Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z) - Drug Induced Liver Injury, Tuberculosis (TB) | Phase 1 | Not yet recruiting | Liaquat National Hospital & Medical College | 410 | 2025-07-01 | 2025-07-10 |
| Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy Nivaquine ® (Chloroquine) - Tuberculosis Infection | Phase 1 | Unknown | University of Zurich | 16 | 2022-01-04 | 2024-07-01 |
| BTZ-043 - Multiple Ascending Dose (MAD) to Evaluate Safety, Tolerability and Early Bactericidal Activity (EBA) BTZ-043, Rifafour e-275®, Probe Drug Cocktail - Pulmonary Tuberculoses, Other Specified Pulmonary Tuberculosis | Phase 1 / Phase 2 | Completed | Michael Hoelscher | 78 | 2019-11-15 | 2026-08-31 |
| Whole Blood Bactericidal Activity Against Mycobacterium Tuberculosis of Pyrazinamide Plus Allopurinol in Healthy Volunteers Pyrazinamide, Allopurinol - Tuberculosis | Phase 1 | Completed | National University Hospital, Singapore | 12 | 2016-02-01 | 2017-04-13 |
| Evaluating Celecoxib Activity in Mycobacterium Tuberculosis: A Whole Blood Bactericidal Activity Study in Healthy Volunteers Celecoxib, Rifampicin, Pyrazinamide - Tuberculosis | Phase 1 | Completed | National University Hospital, Singapore | 18 | 2015-11-01 | 2017-04-13 |
| PK Study of Anti-TB Drugs Isoniazid (H), Rifampicin (R), Pyrazinamide (Z) - Tuberculosis | Phase 1 | Completed | University of Oxford | 61 | 2015-07-07 | 2018-10-03 |
| Clinical Trial to Investigate the Pharmacokinetics of Second-Line Anti-Tuberculosis Agents Levofloxacin and Streptomycin added, Moxifloxacin and Kanamycin added - Healthy | Phase 1 | Completed | Seoul National University Hospital | 16 | 2013-11-01 | 2014-05-01 |
| Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis Rifampicin, Isoniazid, Pyrazinamide - Tuberculosis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 19 | 2008-12-29 | 2019-12-09 |
| Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis Nelfinavir mesylate, Ethambutol hydrochloride, Isoniazid - HIV Infections, Tuberculosis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 44 | 2008-09-11 |
Tuberculosis (7) · AIDS-Related Opportunistic Infections (1) · Chemical and Drug Induced Liver Injury (1) · Gram-Positive Bacterial Infections (1) · HIV Infections (1) · Latent Tuberculosis (1) · Tuberculosis, Pulmonary (1)
National Institute of Allergy and Infectious Diseases (NIAID) (2) · National University Hospital, Singapore (2) · Liaquat National Hospital & Medical College (1) · Michael Hoelscher (1) · Seoul National University Hospital (1) · University of Oxford (1) · University of Zurich (1)
Singapore (2) · South Korea (2) · South Africa (1) · Switzerland (1) · Thailand (1) · United States (1)
Nicholas Paton (2) · Andreas Diacon, Prof (1) · Ariba Sultan (1) · Clifton E Barry, Ph.D. (1) · Constance Benson (1) · Diane Havlir (1) · Marisa Kaelin, Dr. med. (1) · Michael Hoelscher, Prof (1)
PMID 25987620, PMID 26400476, PMID 28739782, PMID 30939136, PMID 39793592, PMID 42156227, PMID 42568101